| Financial Year |
March 31 2023 |
| Monetary Funds |
34,636,092,974.00 |
| Held-for-trading Financial Assets |
4,142,187,027.00 |
| Notes Receivable |
137,669,674.00 |
| Accounts Receivable |
7,706,909,717.00 |
| Advances to Suppliers |
2,046,613,364.00 |
| Other Receivables |
5,230,454,530.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,636,516,618.00 |
| Inventories |
14,144,613,921.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,468,702,266.00 |
| Other Current Assets |
13,958,343,908.00 |
| Total Current Assets |
89,520,053,758.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,312,563,139.00 |
| Long-term Equity Investment |
41,235,421,703.00 |
| Investment Properties |
1,012,852,469.00 |
| Fixed Assetes |
18,873,854,739.00 |
| Under-construction Projects |
1,478,586,261.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,691,101,183.00 |
| R&D expenses |
3,604,016,082.00 |
| Goodwill |
103,180,790.00 |
| Long-Term Deferred and Prepaid Expenses |
593,869,668.00 |
| Deferred Income Tax Assets |
3,957,028,920.00 |
| Other Non-Current Assets |
6,102,894,916.00 |
| Sub-Total of Non-Current Assets |
107,423,520,781.00 |
| Total Assets |
196,943,574,539.00 |
| Short-Term Loans |
8,109,681,196.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,470,889,160.00 |
| Accounts Payable |
18,927,391,919.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,995,814,283.00 |
| Taxes Payable |
705,528,192.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,458,141,232.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,714,895,836.00 |
| Other Current Liabilities |
1,982,476,743.00 |
| Sub-Total of Current Liabilities |
59,986,263,259.00 |
| Long-term Loans |
6,845,719,080.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
983,548,016.00 |
| Deferred Income Tax Liabilities |
145,550,213.00 |
| Other Non-Current Liabilities |
1,492,562,851.00 |
| Sub-Total of Non-Current Liabilities |
13,317,280,395.00 |
| Total Liabilities |
73,303,543,654.00 |
| Paid-In Capital(Or Share Stock) |
10,482,910,241.00 |
| Capital Surplus |
41,237,601,001.00 |
| Surplus Reserve |
5,498,401,539.00 |
| LESS:Treasury Stock |
257,019,161.00 |
| Undistributed Profits |
57,249,054,958.00 |
| Minority Stockholder's Interest |
8,785,667,928.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
114,854,362,957.00 |
| Owner's Equity（Stockholder's Equity） |
123,640,030,885.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
196,943,574,539.00 |
